MEDICAL test kit manufacturer, Trinity Biotech has reported strong second-quarter figures, with a 7% increase in revenue and a 16% rise in earnings per share noted.

MEDICAL test kit provider Trinity Biotech has reported pre-tax profits of $54.2 million (€41.5m) for the first half of the year, up from $6.2m for the same period last year.

MERGERS and acquisitions (M&A) increased 8.8% in the first quarter of 2010 on the same period last year.

An experienced firefighter killed on duty with his young colleague warned superiors weeks before they died of dangerous practices in the local fire service.

THE weakness of the US dollar coupled with lower American sales of its main HIV testing product led to a fall in second-quarter pre-tax profits for Irish medical test kit manufacturer, Trinity Biotech.

TRINITY BIOTECH PLC, Ireland’s largest maker of diagnostic tests, said US regulators approved a product designed to measure blood sugar levels and speed up diabetes tests.

TRINITY Biotech, the Bray-based maker of tests for conditions such as HIV, has announced a shake-up of its senior management.

SHARES in Trinity Biotech plunged yesterday after the company missed its third-quarter sales target.

The value of Irish shares rocketed by more than 3% today, as the ISEQ index saw an amazing 256.58 points to 8240.37.

MERRION Pharmaceuticals, the Dublin-based drug development company, is to launch a €35 million flotation on the Irish and Nasdaq stock markets.

The ISEQ closed up 145.27 points at 9350.43 today, with most of the main players on the index making gains.

ISEQ-listed Trinity Biotech has agreed to provide equipment to New York’s Community Healthcare Network (CHN), introducing rapid HIV testing in the network’s clinics in the Bronx, Brooklyn, Manhattan and Queens.

Brendan Farrell has joined the board of Campbell Informatics as a non-executive director.

The ISEQ closed up 35.39 points at 8575.08 today.

The Dublin stock exchange ended the day with a modest gain in a mixed day for the ISEQ.

The Irish Index continued in negative territory yesterday. The Dublin exchange closed down 55.86 to 7,595.57.

The ISEQ closed up 57.47 points today at 7726.97.

Trinity Biotech’s revenues for the three months to June 30, 2006, increased by 20.3% to $27.3m (€21.2m) compared with the same period in 2005.

TRINITY BIOTECH has entered into an agreement to make the Uni-Gold Recombigen HIV test available to all Planned Parenthood Federation of America affiliates.

Trinity Biotech will host a conference call to discuss its recent acquisition of bioMerieux’s coagulation division at 4pm Irish time today.

The ISEQ index rallied today to close 58.88 points higher at 7510.51.

TRINITY Biotech, the Bray, Co Wicklow-based pharmaceutical company, has reported a 16.4% increase in first-quarter revenues to $24.7 million (€19.7m) for the three months to the end of March.

THE ISEQ Index fell for the second consecutive day as the financials weighed down the market. The Dublin Exchange closed 74.12 points lighter at 7919.22.

Dozens of people were reported dead and more feared missing after a boat capsized off of the coast of Djibouti, an official said today.

The ISEQ index of Irish shares managed to make up for some of it's losses earlier in the week, finishing up 29.64 points to 7975.8.

Dublin's stock exchange had a negative start to the day as it found itself 60.28 points down.

The ISEQ closed at 7972.98 today, up 29.31.

Medical products firm Trinity Biotech, listed on the ISEQ and the NASDAQ, will release 2005 full-year results on Monday, March 6.

Ryanair shares were up 22c to €8.12 this morning as it announced a major expansion of its operations at Dublin Airport.

The Dublin stock exchange had a positive start to the day which saw it rise 21.61 points to 6868.02 by 11am this morning.

The ISEQ index of Irish failed to build on this week's gains as it shed 60.05 to close at 6670.93 today.

The ISEQ index of Irish shares fell 25.63 points to 6705.35 in morning trade today.

Trinity Biotech, the developer and manufacturer of diagnostic products for the point-of-care and clinical laboratory markets, today announced a revenue increase of 25% for the third quarter of the year.

The ISEQ closed up 12.76 points at 6818.91 this evening.

Trinity Biotech today announced that members of its board of directors acquired a total of 4,501,675 ordinary shares in the company by purchasing stock on the open market and exercising share options.

ELECTRONIC payments company Trintech has appointed Maurice Hickey as its new chief financial officer.

DIAGNOSTICS firm Trinity Biotech says it will make a $1m (€822,000) donation of its rapid HIV testing kits to community- based groups and public health facilities in the US.

DIAGNOSTIC test manufacturer Trinity Biotech filed yesterday to periodically sell up to $75 million in Class A ordinary shares and equity warrants.

TRINITY Biotech has completed the acquisition of Research Diagnostics, of Flanders, New Jersey.

Trinity Biotech plc today announced that it has completed the acquisition of Research Diagnostics Inc of Flanders, New Jersey.

The ISEQ index of shares is down 12.71 points after trading today, to end the week at 6,785.59.

The ISEQ's morning rises have been cut back slightly to leave the index up 29.53 points to 6798.3 today.

Minister for Health Mary Harney tonight said she was “disturbed” at revelations donated blood had been sold to 23 drugs firms over a 19-year-period.

The ISEQ index slipped 0.9 today to close at 6,063.12, with shares in Elan falling back today.